Suppr超能文献

热休克蛋白90抑制在犬肺腺癌细胞系中的人类遗传相关性及强大抗肿瘤活性

Human Genetic Relevance and Potent Antitumor Activity of Heat Shock Protein 90 Inhibition in Canine Lung Adenocarcinoma Cell Lines.

作者信息

Clemente-Vicario Francisco, Alvarez Carlos E, Rowell Jennie L, Roy Satavisha, London Cheryl A, Kisseberth William C, Lorch Gwendolen

机构信息

Department of Veterinary Clinical Sciences, College of Veterinary Medicine, The Ohio State University, Columbus, Ohio, United States of America.

Center for Molecular and Human Genetics, The Research Institute at Nationwide Children's Hospital, Columbus, Ohio, United States of America.

出版信息

PLoS One. 2015 Nov 11;10(11):e0142007. doi: 10.1371/journal.pone.0142007. eCollection 2015.

Abstract

BACKGROUND

It has been an open question how similar human and canine lung cancers are. This has major implications in availability of human treatments for dogs and in establishing translational models to test new therapies in pet dogs. The prognosis for canine advanced lung cancer is poor and new treatments are needed. Heat shock protein 90 (HSP90) is an ATPase-dependent molecular chaperone ubiquitously expressed in eukaryotic cells. HSP90 is essential for posttranslational conformational maturation and stability of client proteins including protein kinases and transcription factors, many of which are important for the proliferation and survival of cancer cells. We investigated the activity of STA-1474, a HSP90 inhibitor, in two canine lung cancer cell lines, BACA and CLAC.

RESULTS

Comparative genomic hybridization analysis of both cell lines revealed genetic relevance to human non-small cell lung cancer. STA-1474 inhibited growth and induced apoptosis of both cell lines in a dose- and time-dependent manner. The ICs50 after 72 h treatment with STA-1474 were 0.08 and 0.11 μM for BACA and CLAC, respectively. When grown as spheroids, the IC50 of STA-1474 for BACA cells was approximately two-fold higher than when grown as a monolayer (0.348 μM vs. 0.168 μM), whereas CLAC spheroids were relatively drug resistant. Treatment of tumor-stromal fibroblasts with STA-1474 resulted in a dose-dependent decrease in their relative cell viability with a low IC50 of 0.28 μM.

CONCLUSIONS

Here we first established that lung adenocarcinoma in people and dogs are genetically and biochemically similar. STA1474 demonstrated biological activity in both canine lung cancer cell lines and tumor-stromal fibroblasts. As significant decreases in relative cell viability can be achieved with nanomolar concentrations of STA-1474, investigation into the clinical efficacy of this drug in canine lung cancer patients is warranted.

摘要

背景

人类肺癌与犬类肺癌的相似程度一直是个悬而未决的问题。这对犬类人类治疗方法的可用性以及建立用于在宠物犬中测试新疗法的转化模型具有重大影响。犬类晚期肺癌的预后很差,需要新的治疗方法。热休克蛋白90(HSP90)是一种依赖ATP的分子伴侣,在真核细胞中普遍表达。HSP90对于包括蛋白激酶和转录因子在内的客户蛋白的翻译后构象成熟和稳定性至关重要,其中许多对癌细胞的增殖和存活很重要。我们研究了HSP90抑制剂STA-1474在两种犬类肺癌细胞系BACA和CLAC中的活性。

结果

对两种细胞系的比较基因组杂交分析揭示了与人类非小细胞肺癌的遗传相关性。STA-1474以剂量和时间依赖性方式抑制两种细胞系的生长并诱导其凋亡。用STA-1474处理72小时后,BACA和CLAC的IC50分别为0.08和0.11μM。当以球体形式生长时,STA-1474对BACA细胞的IC50比单层生长时高约两倍(0.348μM对0.168μM),而CLAC球体相对耐药。用STA-1474处理肿瘤基质成纤维细胞导致其相对细胞活力呈剂量依赖性下降,低IC50为0.28μM。

结论

我们首次证实人和犬的肺腺癌在遗传和生化方面相似。STA1474在两种犬类肺癌细胞系和肿瘤基质成纤维细胞中均表现出生物学活性。由于纳摩尔浓度的STA-1474可显著降低相对细胞活力,因此有必要研究该药物在犬类肺癌患者中的临床疗效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c3f/4641597/f7efcc9f44a3/pone.0142007.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验